Aptevo Therapeutics Inc. Deferred Tax Asset, Parent's Basis in Discontinued Operation
Aptevo Therapeutics Inc. (APVO) had Deferred Tax Asset, Parent's Basis in Discontinued Operation of $0 as of 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetParentsBasisInDiscontinuedOperation · last filed 2018-03-13
- 2017-12-31: Deferred Tax Asset, Parent's Basis in Discontinued Operation $0.00.
- 2016-12-31: Deferred Tax Asset, Parent's Basis in Discontinued Operation $10.40M.
| Period end | Deferred Tax Asset, Parent's Basis in Discontinued Operation |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-13 |
| 2016-12-31 | $10.40M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |